Interactions between statins and the farnesoid-X-receptor inhibit positive effects of chenodeoxycholic acid on insulin secretion

被引:0
|
作者
Hoffmeister, T. [1 ]
Kaiser, J. [2 ]
Drews, G. [2 ]
Duefer, M. [1 ]
机构
[1] Inst Pharmaceut & Med Chem, Dept Pharmacol, Munster, Germany
[2] Inst Pharm, Dept Pharmacol & Clin Pharm, Tubingen, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
398
引用
收藏
页码:S198 / S198
页数:1
相关论文
共 50 条
  • [41] Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive, luminal-like breast cancer from postmenopausal patients
    Journe, Fabrice
    Durbecq, Virginie
    Rouas, Ghizlane
    Chaboteaux, Carole
    Laurent, Guy
    Nonclercq, Denis
    Sotiriou, Christos
    Body, Jean-Jacques
    Larsimont, Denis
    ACTA CLINICA BELGICA, 2008, 63 (02): : 127 - 127
  • [42] Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients
    Fabrice Journe
    Virginie Durbecq
    Carole Chaboteaux
    Ghizlane Rouas
    Guy Laurent
    Denis Nonclercq
    Christos Sotiriou
    Jean-Jacques Body
    Denis Larsimont
    Breast Cancer Research and Treatment, 2009, 115 : 523 - 535
  • [43] Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients
    Journe, Fabrice
    Durbecq, Virginie
    Chaboteaux, Carole
    Rouas, Ghizlane
    Laurent, Guy
    Nonclercq, Denis
    Sotiriou, Christos
    Body, Jean-Jacques
    Larsimont, Denis
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (03) : 523 - 535
  • [44] Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model
    P. Comeglio
    S. Filippi
    E. Sarchielli
    A. Morelli
    I. Cellai
    C. Corno
    L. Adorini
    G. B. Vannelli
    M. Maggi
    L. Vignozzi
    Journal of Endocrinological Investigation, 2019, 42 : 951 - 965
  • [45] Characterization of Adverse Effects on Bone Following Administration of Two Non Bile Acid Based Farnesoid X Receptor Agonists in Rats
    Guillot, Martin
    Schumacher, Justin
    Felx, Melanie
    Katavolos, Paula
    Janovitz, Evan
    Achanzar, William
    Boyd, Gabrielle
    Haile, Solomon
    Varela, Aurore
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2024, 43 (01) : 78 - 78
  • [46] Dietary Hyodeoxycholic Acid Exerts Hypolipidemic Effects by Reducing Farnesoid X Receptor Antagonist Bile Acids in Mouse Enterohepatic Tissues
    Watanabe, Shiro
    Fujita, Kyosuke
    LIPIDS, 2014, 49 (10) : 963 - 973
  • [47] Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist
    Weber, Elijah J.
    Younis, Islam R.
    Wang, Lulu
    Xiao, Deqing
    Barchuk, William T.
    Othman, Ahmed A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (06): : 677 - 687
  • [48] Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model
    Comeglio, P.
    Filippi, S.
    Sarchielli, E.
    Morelli, A.
    Cellai, I.
    Corno, C.
    Adorini, L.
    Vannelli, G. B.
    Maggi, M.
    Vignozzi, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (08) : 951 - 965
  • [49] A PRELIMINARY STUDY OF THE EFFECTS OF OBETICHOLIC ACID, A FARNESOID X RECEPTOR AGONIST, IN PATIENTS WITH CHRONIC DIARRHOEA SECONDARY TO CROHN'S ILEAL DISEASE
    Nolan, J. D.
    Vassie, C.
    Johnston, I. M.
    Shapiro, D.
    Walters, J. R.
    GUT, 2014, 63 : A258 - A258
  • [50] Farnesol, an intermediate of the mevalonate pathway, stimulates MCF-7 breast cancer cell growth:: evidence for a positive crosstalk between farnesoid X receptor and estrogen receptor.
    Journe, F.
    Laurent, G.
    Chaboteaux, C.
    Nonclercq, D.
    Body, J-J
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S164 - S165